Rinvoq ER 15 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DB26FDV73
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,203
Award facts
- Contract value 100% obligated
- $11,202.96 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $11,202.96 to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count units), a medication used to treat rheumatoid arthritis and other inflammatory conditions. This competitive, non-set-aside award was issued on October 30, 2025, with performance completion scheduled for October 31, 2025. The contract employs firm fixed pricing and represents a delivery order under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement supporting military and veteran healthcare systems. The company's extensive portfolio under the SPE2DX contract encompasses brand-name and generic medications, vaccines, specialty pharmaceuticals, and medical supplies across multiple therapeutic domains. This delivery order exemplifies the company's role in supplying pharmaceutical products to support Defense Health Agency operations and broader federal healthcare requirements through the DLA's comprehensive global pharmaceutical supply program.
Quick answers
Who was awarded contract SPE2DB26FDV73?
SPE2DB26FDV73 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 30, 2025.
How much is contract SPE2DB26FDV73 worth?
The government has obligated $11,203 on SPE2DB26FDV73.
Is contract SPE2DB26FDV73 an order under another contract?
Yes. SPE2DB26FDV73 is a delivery order under SPE2DB22D2206, an indefinite delivery contract.
Was contract SPE2DB26FDV73 competed?
The extent of competition for SPE2DB26FDV73 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award